Default company panoramic image

Empire Genomics

A leading firm in the rapidly growing area of cancer molecular diagnostics which defines personalized treatments based on a patient's genome

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded April 2006
  • Employees 10
  • Website

Company Summary

Having played a fundamental role in the Human Genome Project Empire Genomics developed significant expertise in translating genomic research into clinical results. Empire provides kits, assays and clinical trial services to the global pharmaceutical, hospital and research institutes which assisted in more precise diagnosis of disease and targeted therapy. These services reduce the costs to the heatlhcare system and reduce drug side effects.


  • Default avatar
    Anthony Johnson

    Anthony brings considerable experience in the sales and management of products and services to the research and regulated industries. His creative perspective to implementing successful sales and marketing strategies, early stage funding, joint ventures and daily management are a strong asset to Empire Genomics. Formerly, in the capacity as Business Area Manager for Stem Cell and Regenerative Medicine for Invitrogen Corporation's GIBCO business u

  • Default avatar
    Norma J Nowak

    A leader in the field of genomics, Norma's research contributed directly to the Human Genome Project and approaches to understanding cancer. Among her major achievements, Norma has authored landmark papers describing the cloning of several heritable cancer disorders. Her work on the Human Genome Project was published in the genome issue of Nature. Dr. Nowak, who has received more than $4 million in research grants from the National Institutes

  • Default avatar
    Michael Zwick
    VP Research Operations

    Michael brings over 19 years experience in the life science industry and has been involved in multiple sectors including diagnostics, research reagents, contract research and therapeutics. He has been responsible for research and development, sales, marketing and project management and held senior positions at AndroBioSys, NeoClone Biotechnology, IMMCO Diagnostics, Medic Group, Promega Corporation, and Ribozyme Pharmaceuticals (SiRNA). He is adep

  • Default avatar
    Theresa Brown
    Director Clinical Lab

    Theresa has over 20 years of experience in the field of genetics. Beginning as a cytogenetic technologist, then gaining experience in molecular genetic testing, and for the past ten years has been a director in cytogenetic reference labs including IMPATH, Genzyme Genetics and CSI laboratories. Theresa’s area of expertise is the cytogenetics of leukemias and lymphomas, with previous experience in growing a small clinical laboratory.



  • Default avatar
    LMWF, Lawson Weitzen
    Default avatar
    Dopkins Company

Previous Investors

  • Default avatar